Acadia Pharmaceuticals Stock Price - ACAD

41.74
1.52 (3.78%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Acadia Pharmaceuticals Inc ACAD NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.45 -1.11% 40.22 39.57 42.04 40.93 40.67 20:00:00
Bid Price Ask Price Spread Spread % News
41.03 41.86 0.83 1.98% - 1
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
14,389 1,192,685 $ 40.51 $ 48,314,248 1,257,821 21.56 - 54.60
Last Trade Time Type Quantity Stock Price Currency
19:54:06 formt 332 $ 41.74 USD

Acadia Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 6.19B 154.03M $ -245.19M -1.95 -36.57 153.46M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Acadia Pharmaceuticals News

Latest ACAD Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ACAD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week45.5646.0439.5743.451,110,817-5.34-11.72%
1 Month41.4547.9939.0743.231,019,939-1.23-2.97%
3 Months45.0754.6037.5344.271,501,802-4.85-10.76%
6 Months28.3254.6023.7741.781,753,95011.9042.02%
1 Year23.4854.6021.5635.251,507,70216.7471.29%
3 Years38.7854.6012.7726.441,906,9751.443.71%
5 Years37.4854.6012.7728.731,941,6942.747.31%

Acadia Pharmaceuticals Description

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Your Recent History
NASDAQ
ACAD
Acadia Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200227 02:58:51